Trials / Withdrawn
WithdrawnNCT01735812
Laparoscopic Cryoablation of Uterine Fibroids
Cryoablation of Symptomatic Uterine Fibroids Using the IceSense3™ System in a Percutaneous Laparoscopic-assisted Approach
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- IceCure Medical Ltd. · Industry
- Sex
- Female
- Age
- 30 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this study is to evaluate the safety \& efficacy of cryoablation using IceCure medical's IceSense3™ device for the treatment of symptomatic uterine fibroids in a percutaneous lap-assisted approach.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | IceSense3 system | The IceSense3™ is a modern cryosurgical device that was designed by IceCure Medical for a variety of applications. |
Timeline
- Start date
- 2012-12-01
- Primary completion
- 2015-12-01
- Completion
- 2015-12-01
- First posted
- 2012-11-28
- Last updated
- 2022-06-13
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT01735812. Inclusion in this directory is not an endorsement.